Sign in →

Test ID TPSF Protein, Total, Spinal Fluid

Useful For

To detect increased permeability of the blood-brain barrier to plasma proteins

 

To detect increased intrathecal production of immunoglobulins

Method Name

Reflectance Spectrophotometry

Reporting Name

Protein, Total, CSF

Specimen Type

CSF

Container/Tube: Sterile vial

Specimen Volume: 1 mL

Collection Instructions: Centrifuge specimen to remove any cellular material.

Specimen Minimum Volume

0.25 mL

Specimen Stability Information

Specimen Type Temperature Time
CSF Refrigerated (preferred) 72 hours
  Frozen  180 days

Clinical Information

Cerebrospinal fluid (CSF) is secreted by the choroid plexuses, around the cerebral vessels, and along the walls of the ventricles of the brain. It fills the ventricles and cisternae, bathes the spinal cord, and is reabsorbed into the blood through the arachnoid villi. CSF turnover is rapid, exchanging about four times per day. More than 80% of CSF protein content originates from plasma by ultrafiltration through the walls of capillaries in the meninges and choroid plexuses; the remainder originates from intrathecal synthesis. Because CSF is mainly an ultrafiltrate of plasma, low-molecular plasma proteins such as prealbumin, albumin, and transferrin predominate. No protein with a molecular weight greater than that of IgG is present in sufficient concentration to be visible on electrophoresis.

 

The permeability of the blood-brain barrier to plasma proteins is increased by high intracranial pressure due to brain tumor; intracerebral hemorrhage; traumatic injury; or by inflammation due to bacterial or viral meningitis, encephalitis, or poliomyelitis.

 

Increased intrathecal synthesis of immunoglobulins, particularly IgG, is seen in demyelinating diseases of the central nervous system (CNS), especially multiple sclerosis. Increased immunoglobulins are also seen in other chronic inflammatory diseases of the CNS such as chronic meningoencephalitis due to bacteria, viruses, fungi or parasites; subacute sclerosing panencephalitis; and Guillian-Barre syndrome.

Reference Values

≥12 months: 0-35 mg/dL

Reference values have not been established for patients that are <12 months of age.

Cautions

Specimens should be collected prior to the intrathecal administration of contrast media. Significant positive bias can occur when cerebrospinal fluid (CSF) contains contrast media. If possible, the patient should be recumbent for about one hour before the specimen is drawn. Erect posture causes a redistribution of the body fluid, increasing total serum protein concentration.

 

Blood in the CSF specimen invalidates the protein value.

Day(s) Performed

Monday through Sunday; Continuously

Report Available

Same day/1 day

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

84157

NY State Approved

Yes